ReviewJournal of personalized medicine2021

Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities.

Nikolaos Garmpis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.